1,3,3-Trimethyl-6′-(4-phenylpiperazin-1 -yl)-2,3-dihydrospiro[1H-indole-2,3′-3H-naphth-[2,1-b][1,4]oxazine]

Hui Guo,Yongbin Gao,Yanxia Li,Jie Han,Jiben Meng
DOI: https://doi.org/10.1107/S1600536805007063
2005-01-01
Abstract:The title compound, C32H32N4O, a spirooxazine modified with a fused phenyl-piperazinyl-naphthalene moiety, has been characterized by X-ray crystallographic techniques. The piperazine ring is in a chair conformation, while the oxazine and pyrrolidine rings adopt envelope conformations. © 2005 International Union of Crystallography Printed in Great Britain - all rights reserved.
What problem does this paper attempt to address?